ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1304

The role of PET/CT in evaluating rheumatologic conditions in children with fever of unknown origin – a multicenter study

Neta Berlak1, Lydia Christodoulou2, Gil Amarilyo3, Oded Scheuerman4, Irit Tirosh5, Eyal Kristal6, Ester Forer7, Amit Carmi8, Alon Kalter9 and Yoel Levinsky10, 1Schneider children's medical center of Israel, Tel Aviv, Israel, 2Tel Hashomer, Periatric rheumatology unit, Tel Aviv, Israel, 3Schneider Children's Medical Center of Israel, Kibbutz Maggal, Israel, 4schneider children's meidcal center of Israel, Petah tikva, Israel, 5Tel Aviv universty, Ramat Gan, Israel, 6Soroka medical center Beer Sheva, Beer Sheva, Israel, 7Soroka medical center, Beer Sheva, Israel, 8Schneider children's meidcal center of Israel, Tel Aviv, Israel, 9Schneider children's medical center of ISrael, Petah Tikva, Israel, 10Schneider Children's Medical Cenetr of Israel, Tel Aviv University, JERUSALEM, Israel

Meeting: ACR Convergence 2025

Keywords: Imaging, Infection, Inflammation, Juvenile idiopathic arthritis, Pediatric rheumatology

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1272–1305) Pediatric Rheumatology – Clinical Poster II

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Fever of Unknown Origin (FUO) is a relatively common clinical challenge that is frequently referred for evaluation by pediatric rheumatologists. In many cases, it is necessary to rule out other medical conditions before establishing a rheumatologic diagnosis. 18F-FDG PET/CT is a valuable diagnostic tool that may help identify the fever’s source. However, its use in children involves risks, including radiation exposure and the need for sedation. Our aims were To assess the contribution of PET/CT to FUO diagnosis in hospitalized children, and to identify rheumatologic conditions that are either detected through the evaluation or excluded by it. In addition, to identify predictive factors for its diagnostic utility.

Methods: A retrospective cohort study reviewing medical records of children (0-18 years) diagnosed with FUO who underwent PET/CT between 2010 and 2024 in three Israeli medical centers. Clinical and laboratory data were collected, and cases where PET/CT led to a diagnosis were compared to those where it did not.

Results: Among 113 cases, PET/CT contributed to diagnosis in 52 (46%). The majority of diagnoses identified by PET/CT were infectious (53.8%), whereas in cases where PET/CT did not aid in diagnosis, rheumatologic diseases were predominant (66.6%). Of all cases, 21% were ultimately diagnoses with a rheumatologic condition, the most frequent was systemic JIA. Immunodeficiency, low hemoglobin, and low albumin were more frequent in cases where PET/CT was diagnostic, while rash and arthritis were more common in cases where PET/CT did not contribute.

Conclusion: PET/CT is an effective diagnostic tool for FUO in children, aiding diagnosis in 46% of cases. Of all cases, 21% were ultimately diagnoses with a rheumatologic condition. However, most were diagnosed without direct findings on the PET/CT, which primarily served to rule out other conditions. Predictive factors for its utility are reported. In appropriate clinical scenarios, PET/CT should be considered as part of the FUO workup in pediatric patients.

Supporting image 1Table 1

Supporting image 2Table 2


Disclosures: N. Berlak: None; L. Christodoulou: None; G. Amarilyo: None; O. Scheuerman: None; I. Tirosh: None; E. Kristal: None; E. Forer: None; A. Carmi: None; A. Kalter: None; Y. Levinsky: None.

To cite this abstract in AMA style:

Berlak N, Christodoulou L, Amarilyo G, Scheuerman O, Tirosh I, Kristal E, Forer E, Carmi A, Kalter A, Levinsky Y. The role of PET/CT in evaluating rheumatologic conditions in children with fever of unknown origin – a multicenter study [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/the-role-of-pet-ct-in-evaluating-rheumatologic-conditions-in-children-with-fever-of-unknown-origin-a-multicenter-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-role-of-pet-ct-in-evaluating-rheumatologic-conditions-in-children-with-fever-of-unknown-origin-a-multicenter-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology